Search
01/03/2024
Randomized controlled trials in nursing conducted by Latin American research teams: A scoping review
Medina-Aedo, M, Segura-Carrillo, C, Torralba-Martinez, E, Buitrago-García, D, Solà, I, Pardo-Hernandez, H, Bonfill, X. Randomized controlled trials in nursing conducted by Latin American research teams: A scoping review. JOURNAL OF NURSING SCHOLARSHIP. 2024; 56(2)DOI:10.1111/jnu.12943. PMID:37965861. IF:2.900(Q1/2D).
01/03/2024
Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
Stockbauer, A, Beyer, L, Huber, M, Kreuzer, A, Palleis, C, Katzdobler, S, Rauchmann, BS, Morbelli, S, Chincarini, A, Bruffaerts, R, Vandenberghe, R, Kramberger, MG, Trost, M, Garibotto, V, Nicastro, N, Lathuilière, A, Lemstra, AW, van Berckel, BNM, Pilotto, A, Padovani, A, Ochoa-Figueroa, MA, Davidsson, A, Camacho, V, Peira, E, Bauckneht, M, Pardini, M, Sambuceti, G, Aarsland, D, Nobili, F, Gross, M, Vöglein, J, Perneczky, R, Pogarell, O, Buerger, K, Franzmeier, N, Danek, A, Levin, J, Höglinger, GU, Bartenstein, P, Cumming, P, Rominger, A, Brendel, M. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; DOI:10.1007/s00259-023-06493-w. PMID:37971501. IF:7.600(Q1/1D).
01/03/2024
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
Torres, T, Chiricozzi, A, Puig, L, Lé, AM, Marzano, AV, Dapavo, P, Dauden, E, Carrascosa, JM, Lazaridou, E, Duarte, G, Carvalho, AVE, Romiti, R, Rompoti, N, Teixeira, L, Abreu, M, Ippoliti, E, Maronese, CA, Llamas-Velasco, M, Vilarrasa, E, del Alcázar, E, Daponte, AI, Papoutsaki, M, Carugno, A, Bellinato, F, Gisondi, P. Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024; 25(2)DOI:10.1007/s40257-024-00845-4. PMID:38265746. IF:8.800(Q1/1D).
01/03/2024
Down Syndrome Biobank Consortium: A perspective
Aldecoa, I, Barroeta, I, Carroll, SL, Fortea, J, Gilmore, A, Ginsberg, SD, Guzman, SJ, Hamlett, ED, Head, E, Perez, SE, Potter, H, Molina-Porcel, L, Raha-Chowdhury, R, Wisniewski, T, Yong, WH, Zaman, S, Ghosh, S, Mufson, EJ, Granholm, AC. Down Syndrome Biobank Consortium: A perspective. ALZHEIMERS & DEMENTIA. 2024; 20(3)DOI:10.1002/alz.13692. PMID:38270275. IF:11.100(Q1/1D).